Improving cancer research in underserved communities using advanced data analysis.
Biostatistics and Bioinformatics Core (BBC)
This study is all about helping researchers find better ways to understand and tackle cancer, especially for underserved communities in Philadelphia, New Jersey, and New York City, by using smart technology and teamwork.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10931736 on NIH RePORTER |
What this research studies
This project focuses on enhancing cancer health disparities research by providing specialized support in biostatistics and bioinformatics. It aims to assist researchers in designing experiments and analyzing data, particularly for underserved African-, Asian-, and Latinx American communities in Philadelphia, New Jersey, and New York City. The core team utilizes advanced techniques such as machine learning and artificial intelligence to develop innovative methods for tackling cancer-related issues. By collaborating with various research projects, the core aims to improve the quality and impact of cancer research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals from African, Asian, and Latinx American communities who are affected by cancer.
Not a fit: Patients outside of the specified underserved communities or those not affected by cancer may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and interventions tailored to the needs of underserved populations.
How similar studies have performed: Previous research has shown success in using biostatistics and bioinformatics to address health disparities, indicating that this approach is promising.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Ross, Eric Andrew — Temple Univ of the Commonwealth
- Study coordinator: Ross, Eric Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.